News

Interview with HITLAB on Medical Data Infrastructure, Automation and AI

In this video interview with HITLAB at Columbia University in New York, Hexoskin's CEO Pierre-Alexandre Fournier discusses how fundamental building medical data infrastructure was to enable automation and AI - tools to make healthcare delivery more efficient and more accessible.

The lack of electronic medical records and data standards has slowed progress in digital health and AI in the 2000s and 2010s. Today the infrastructure is ready to make data collected by patients actionable and valuable.

This new IT environment (EHR/EMRs, broadband, FIRH, HL7, smart phones, and wearables) accelerates automation and AI development, digital biomarker discovery, personalized medicine and new health prevention services.

Hexoskin is building on this infrastructure to offer high-resolution vital signs monitoring with Hexoskin and Astroskin wearables, apps to collect patient reported outcomes and events, could storage, data automation and cohort management.

Please reach out to see how Hexoskin can help.

Hexoskin at HITLAB Digital Health Summit 2023 in New York

Hexoskin's co-founder and CEO, Pierre-Alexandre Fournier, has been invited to speak at the prestigious HITLAB Innovator Summit 2023, hosted at Columbia University in New York City this June 27-29.

In the past 10 years we have seen enormous progress in the use of digital technologies in healthcare to support a wide range of activities: remote care, remote diagnostics, access to medical data, artificial intelligence, virtual clinical trials, genetic analysis, digital biomarker development, molecule discovery, etc. Despite all this progress, patients, physicians, scientists and researchers agree we have barely started to use digital tools to address our growing need for efficient healthcare, therapies and population health management.

The event includes speakers from Merck, Takeda, Pfizer, Syneos, Medidata, CVS, Novo Nordisk, Microsoft, Mount Sinai Health System, Brigham and Women’s Hospital, and many other organizations working to improve human health and access to care.

Please reach out to us if you'd like to arrange a meeting during the event: contact@hexoskin.com

Tickets are still available, and you can get 20% off with the special code SUMMITPAF23.

About Hexoskin

Founded in 2006 in Montreal, Hexoskin is a leader in wearable sensors, software, data science & AI services. The company provides solutions and services to researchers & professionals in pharmaceuticals, academics, healthcare, defense, first responders, space, and aerospace organizations.

CGI and Hexoskin to Work Together on Connected Medical Clinic Project

The Canadian Space Agency (CSA) has awarded contracts to five teams to build prototypes of the Connected Care Medical Module (C²M²), a container-based concept for mobile medical clinics that can be rapidly deployed in remote, northern, or indigenous communities across Canada, in regions affected by natural disasters, and in future lunar and deep space missions.

Hexoskin (Carré Technologies Inc.) is proud to be part of the HARMONY team, led by CGI, one of the largest IT firms in the world, along with OKAKI Health Intelligence, PrecisionOS Technology, 12Volt: Games Studio, and Dr. Carolyn McGregor of the University of Ontario Institute of Technology.

Hexoskin will contribute Astroskin devices and AI-based medical software to the project. A first demonstration is planned for June 2023.

About the Connected Care Medical Modules

Health Beyond's vision is to enable agile, rapid prototyping and iterative operation of C²M²s on Earth, with the ultimate objective of operation in space. A C²M² is a scalable integrated system of state-of-the-art medical technologies and methodologies contained in a deployable unit. A shipping container will first be used for research and development purposes and for easy deployment across Canada via the existing intermodal freight transportation network. When preparing for space application and deployment in remote communities with collaborators, the medical module can be scaled down and adapted as needed.

One of the novel features of the C²M² is its core computer-based system that facilitates the incorporation, interconnection (i.e., flow of information), and usage of the latest medical technologies. This plug and play architecture will enable multiple configurations based on the end users' needs. These technologies increase the user's capacity to independently detect, diagnose, treat, and/or monitor health conditions on site. This improves the timeliness, quality, and continuity of care; refines clinical decision-making; and reduces the occurrence of risky and expensive medical transportation of patients from remote regions to urban hospital facilities.

(photo: Canadian Space Agency)

Hexoskin to Support Medical Research and Covid-19 Response

Hexoskin has been working with governements and health systems in the US and Canada to define actions to support healthcare services during the COVID-19 response.

We are currently putting in place patient monitoring programs in hospitals and at home for COVID-19 patients. These projects are important to support telehealth services, but also to gather data for medical research and manage the public response to the virus. We are now working on onboarding our first COVID-19 patients.

The data collected will also be used to develop AI/machine learning software to better assess the risk of COVID-19 patients recovering at home. Hexoskin biometric shirts can continuously measure respiration effort in addition to cardiac activity, which provides unique data to understand the evolution of the disease and its effects on lung function.

We are also working with health systems on rapidly setting up programs to ensure the continuity of care for patients currently enrolled in cardiac and pulmonary rehabilitation programs with online tools.

We understand that hospitals are currently focused 100% on hospitalized patients, that's why Hexoskin is setting up telehealth teams of its own and offering these resources to support these programs and complement health systems' resources.

If you are looking for help for telehealth programs or COVID-19 home monitoring programs please contact us today: contact@hexoskin.com / 1-888-887-2044

Hexoskin Receives 2022 International Space Station Research Innovation Award for Human Health in Space from American Astronautical Society

 Washington, D.C. - July 28th, 2022

The American Astronautical Society has awarded today the 2022 International Space Station Research Innovation Award for Human Health in Space to Hexoskin (Carré Technologies Inc.) for demonstrating a comprehensive physiology monitoring system for use in research and in situ crew care.

The Astroskin Bio-Monitor System was launched with SpaceX mission CRS-16 in December 2018 and was commissioned by Canadian astronaut David Saint-Jacques in January 2019. It is currently used in two clinical trials in microgravity to improve our understanding of cardiovascular health in space and physiological models of aging. These studies will help support human health during long-term space missions beyond Earth's orbit: to the Moon, Mars, and beyond.

"This award celebrates 10 years of collaboration between Hexoskin and space agencies, and a technology that has a real impact on medical research in space and in our communities" said Pierre-Alexandre Fournier, CEO and co-founder of Hexoskin.

The Hexoskin space medicine team supports the operations of the Astroskin Bio-Monitor in space with the collaboration of the Canadian Space Agency, NASA, and other space agencies and subcontractors.

About Astroskin

Astroskin is the most advanced ambulatory vital signs monitoring platform for medical research in the world. Developed to qualify for space research, it can now benefit the most innovative research in Space and on Earth.

Astroskin offers state-of-the-art continuous real-time monitoring for 48 hours of blood pressure, pulse oximetry, 3-lead ECG, respiration, skin temperature, and activity.

The Astroskin garments are now available in a wide range of sizes for men & women. A large number of research organizations already use the Astroskin vital signs monitoring platform to collect data to answer their research questions.

About the ISS R&D Conference

The International Space Station Research and Development Conference (ISSRDC) brings together leaders from the commercial sector, U.S. government agencies, and academic communities to foster innovation and discovery onboard the International Space Station (ISS).

The conference is hosted by the Center for the Advancement of Science in Space, Inc., manager of the ISS National Laboratory; NASA; and the American Astronautical Society (AAS). ISSRDC showcases how the space station continues to provide a valuable platform for research and technology development that benefits humanity and enables a robust and sustainable market in low Earth orbit. Additionally, the ISSRDC marketplace expo allows companies to showcase how they are advancing opportunities in low Earth orbit and provides a venue to meet with researchers, stakeholders, and policymakers.

About the American Astronautical Society

The American Astronautical Society (AAS), established in 1899, is a major international organization of professional astronomers, astronomy educators, and amateur astronomers. Its membership of approximately 8,000 also includes physicists, geologists, engineers, and others whose interests lie within the broad spectrum of subjects now comprising the astronautical sciences.

The mission of the AAS is to enhance and share humanity’s scientific understanding of the universe as a diverse and inclusive astronautical community, which it achieves through publishing, meetings, science advocacy, education and outreach, and training and professional development.

AGE-WELL Webinar - Monitoring Heart and Lung Health Using Innovative Technologies in 2022

 

Heart disease affects 1.3 million Canadians. There are technologies that can help patients receive better care at home, and better manage their health and symptoms.

Our Hexoskin CEO, Pierre-Alexandre Fournier was invited by AGE-WELL to discuss about innovative monitoring solutions for cardiac and pulmonary diseases, like Hexoskin Smart Clothing, that can help patients in managing and monitoring their health condition.

You can watch the event here.

Make sure to subscribe to our Hexoskin Newsletter to receive the latest news and early invitations to our upcoming events! 

Hexoskin Talks Space Medicine at the Healthcare without Boundaries Colloquium

Biomedical researcher Héloïse Auger will talk about Hexoskin's work in space medicine, Astroskin wearable sensors, and artificial intelligence for automated diagnostics at the Healthcare without Boundaries Colloquium this week on June 1-2. Registration is available on Eventbrite: Healthcare without Boundaries Colloquium

Hexoskin has been collaborating with the Canadian Space Agency since 2011 on the development of medical technologies that can be used for human spaceflight. Devices that can record health data passively, like the Astroskin, create an opportunity to develop autonomous medical systems using clinical rules and artificial intelligence to support long-term space missions beyond low Earth orbit.

Stanford Wearable Electronic Initiative - Hexoskin Seminar

Hexoskin's CEO Pierre-Alexandre Fournier was invited to speak at a seminar co-hosted by Stanford eWEAR and Stanford Medicine's Precision Health and Integrated Diagnostics Center (PHIND) held online on December 1st. The seminar covered the capabilities of wearable technologies and Hexoskin to support the early detection of diseases such as the COVID-19 onset.

With over 100 Scientific Publications and validations, Hexoskin has the only clinically validated biometric garment which provides continuous monitoring of numerous and unique physiological parameters. It is an enabling technology for telehealth use cases, such as remote patient monitoring, at-home cardiovascular and pulmonary rehabilitation, and post-acute care.

Along with its smart clothing, Hexoskin offers a unique set of high-resolution biometric data that can continuously monitor activity, sleep, cardiac and respiratory data. Projects in fields such as cardiology, respiratory, behavioral and physiological psychology, biofeedback research, sleep research, and health will be presented during the seminar.

The Hexoskin Connected Health Platform provides researchers with accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, annotate, analyze, and export raw & processed health data. Data extraction tools allow access to the raw data with time series for machine learning and artificial intelligence projects, making Hexoskin and excellent solution to collect high-resolution data quickly to deliver projects and results. Watch it online today!

Now 100+ Publications with Hexoskin!

Today Hexoskin has reached an important milestone. The Hexoskin Connected Health Platform has been used in over 100 scientific & peer-reviewed publications thanks to our community of researchers and scientists dedicated to promoting safe and effective remote monitoring technologies!

But who’s counting? Actually... we do! Our Hexoskin Smart Clothing solutions benefit from the most validation and publications in the industry, accounting for more than all the smart clothing competition combined.

A Connected Health Platform Fit for Various Research Fields

The publications and validations studies cover a wide range of fields of study from scientific validations of the Hexoskin Cardiac, Pulmonary, and Activity smart clothing sensors; to various subjects and health applications.

It’s been such a wonderful experience to reach this milestone and we are thankful for the trust placed in our Hexoskin Connected Health Solutions. We can’t wait to continue this journey to improve evidence-based practice for patients and professionals by bringing science to new levels! 

Hexoskin and Halo Health to solve key challenges of clinical trials.

Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.

These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.

Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.

Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.

Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”

Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.

We’re attending #DPHARM2019 in #Boston, at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials! 

Contact Hexoskin to learn more.